Anteris Technologies (AVR)
Develops the investigational DurAVR valve system built on ADAPT tissue.
$8.51
Pre-market−0.09 (−1.05%)
At close$8.60(+1.78%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
estimated · in 69 days
EPS estimate
−$0.31
Revenue estimate
$2.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Feb '26May '26Aug '26Aug '26Nov '26
Reported−$0.61−$0.58−$0.62−$0.75−$0.28—−$0.30Pending
Estimate−$0.45−$0.50−$0.56−$0.50−$0.27−$0.21−$0.21−$0.31
Surprise−35.6%−16.0%−10.7%−49.0%−3.4%—−44.7%—
RevenueReportedEstimate
May '25Aug '25Nov '25Feb '26May '26Aug '26Aug '26Nov '26
Reported$556.0K$618.0K$429.0K$303.0K$494.0K$1.0M$1.0MPending
Estimate$584.3K$1.2M$307.5K$200.0K$766.7K$1.5M$1.5M$2.8M
Surprise−4.8%−49.7%+39.5%+51.5%−35.6%−32.7%−32.7%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.31 | — | — |
| Aug 2026 | −$0.21 | −$0.30 | −44.7% |
| Aug 2026 | −$0.21 | — | — |
| May 2026 | −$0.27 | −$0.28 | −3.4% |
| Feb 2026 | −$0.50 | −$0.75 | −49.0% |
The latest year is open to everyone — the 4 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.31 | — | — | $2.8M | — | — | — |
| Aug 11, 2026 | −$0.21 | −$0.30 | −44.7% | $1.5M | $1.0M | −32.7% | +2.3% |
| Aug 10, 2026 | −$0.21 | — | — | $1.5M | $1.0M | −32.7% | +2.3% |
| May 12, 2026 | −$0.27 | −$0.28 | −3.4% | $766.7K | $494.0K | −35.6% | −2.5% |
| Feb 26, 2026 | −$0.50 | −$0.75 | −49.0% | $200.0K | $303.0K | +51.5% | +2.7% |
The latest year is open to everyone — the 4 quarters behind it read with an account. Sign in | |||||||
| Nov 12, 2025 | |||||||
| Aug 11, 2025 | |||||||
| May 13, 2025 | |||||||
| Apr 29, 2025 | |||||||